HB 17 Mississippi House · 2025 Regular Session

Protecting Patient Access to Physician-Administered Drugs Act; create.

HB 17, the "Protecting Patient Access to Physician-Administered Drugs Act," prevents health insurance companies from refusing to cover or charging extra fees for drugs that must be administered by a doctor (like certain IV treatments or injections). It requires insurers to pay doctors and clinics the agreed-upon rate or wholesale cost for these drugs when medically necessary, and prohibits patients from being charged additional fees to get them from their regular provider. The law directly affects patients covered by health insurance, physicians, clinics, and insurance companies in Mississippi. It became law without the governor’s signature in March 2025.
Bill status signed all 5 stages cleared
Introduction
Feb 2025
Committee Review
Mar 2025
House Passage
Feb 2025
Senate Passage
Mar 2025
Signed into Law
Mar 2025
Introduced Feb 13, 2025 Signed Mar 21, 2025
Maddy AI version diff · 2 comparisons

What changed between versions

As Passed the lower Current version · 1 edit
MINOR
The bill title and status were updated to reflect its progression from the House to the Governor, indicating it has passed the House and is awaiting final review. No substantive policy changes, scope modifications, or new provisions were identified in the provided text.
TECHNICAL

The bill header was updated from 'As Passed the House' to 'As Sent to Governor', and the subtitle was similarly changed to reflect the bill's current legislative status.

Floor votes · Senate Mar 7, 2025 · House Feb 12, 2025

How they voted

480
Passed · 3 other
Total votes 51
Mar 7, 2025
D Democratic16
15 Yea 1
93% Yea
R Republican35
33 Yea 2
94% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
11
Key actions
4
Committee
4
Mar 7, 2025
Upper · Passed
Passed
upper
Mar 4, 2025
Upper · Passed
Title Suff Do Pass
upper
Feb 17, 2025
Committee
Referred To Insurance
upper
Feb 13, 2025
Introduced
Transmitted To Senate
lower
Feb 12, 2025
Lower · Passed
Passed
lower
Jan 30, 2025
Lower · Passed
Title Suff Do Pass
lower
Jan 10, 2025
Committee
Referred To Drug Policy
lower
1 primary · 1 co-sponsor

Sponsors